Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 4, 2010, Pages 400-406

  Ghanbari, Hamid ^a   Feldman, Dustin ^a   Schmidt, Martin ^b   Ottino, Jessica ^a   MacHado, Christian ^a   Akoum, Nazem ^c   Wall, T Scott ^c   Daccarett, Marcos ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Anticoagulation; Bridging; Cardiac; Resynchronization; Therapy; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HEART RHYTHM; HEMATOMA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROSTHESIS; PATIENT SAFETY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HEMATOMA; HEPARIN; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; POSTOPERATIVE HEMORRHAGE; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; WARFARIN; WITHHOLDING TREATMENT;

EID: 77950515734     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02703.x     Document Type: Article

References (20)

1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 2006 48 : 854 906. (Pubitemid 44175743)
2. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, Ansell J. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 2008 133 : 299S 339S. (Pubitemid 351894915)
3. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997 336 : 1506 1511.
4. Giudici MC, Paul DL, Bontu P, Barold SS. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol 2004 27 : 358 360.
5. al-Khadra AS. Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol 2003 26 : 511 514.
6. Larson BJ, Zumberg MS, Kitchens CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest 2005 127 : 922 927.
7. Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Am Heart J 2009 158 : 252 256.
8. Tolosana JM, Berne P, Mont L, Heras M, Berruezo A, Monteagudo J, Tamborero D, et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: Oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. Eur Heart J 2009 30 : 1880 1884.
9. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: A systematic review. Arch Intern Med 2003 163 : 901 908.
10. Blacker DJ, Wijdicks EF, McClelland RL. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 2003 61 : 964 968.
11. Douketis JD, Crowther MA, Cherian SS, Kearon CB. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 1999 116 : 1240 1246.
12. Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AG, Bates SM, Desjardins L, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004 110 : 1658 1663.
13. Marquie C, De Geeter G, Klug D, Kouakam C, Brigadeau F, Jabourek O, Trillot N, et al. Post-operative use of heparin increases morbidity of pacemaker implantation. Europace 2006 8 : 283 287.
14. Michaud GF, Pelosi F Jr., Noble MD, Knight BP, Morady F, Strickberger SA. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 2000 35 : 1915 1918.
15. Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, et al. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 2009 32 : 378 382.
16. Spyropoulos AC, Turpie AG, Dunn AS, Kaatz S, Douketis J, Jacobson A, Petersen H. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol 2008 102 : 883 889.
17. Goldstein DJ, Losquadro W, Spotnitz HM. Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 1998 21 : 1730 1734.
18. Wiegand UK, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, Bode F. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: Influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 2004 126 : 1177 1186.
19. Milic DJ, Perisic ZD, Zivic SS, Stanojkovic ZA, Stojkovic AM, Karanovic ND, Krstic NH, et al. Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment. Europace 2005 7 : 374 379.
20. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009 16 : 1661 1670.